These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17903080)

  • 1. Women's willingness to accept perceived risks for vasomotor symptom relief.
    Johnson FR; Ozdemir S; Hauber B; Kauf TL
    J Womens Health (Larchmt); 2007 Sep; 16(7):1028-40. PubMed ID: 17903080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.
    Johnson FR; Hauber AB; Ozdemir S; Lynd L
    Value Health; 2010; 13(4):418-23. PubMed ID: 20230550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.
    Johnson FR; Ozdemir S; Mansfield C; Hass S; Miller DW; Siegel CA; Sands BE
    Gastroenterology; 2007 Sep; 133(3):769-79. PubMed ID: 17628557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.
    Johnson FR; Hauber B; Özdemir S; Siegel CA; Hass S; Sands BE
    J Manag Care Pharm; 2010 Oct; 16(8):616-28. PubMed ID: 20866166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current recommendations: what is the clinician to do?
    Manson JE
    Fertil Steril; 2014 Apr; 101(4):916-21. PubMed ID: 24680650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are adult patients more tolerant of treatment risks than parents of juvenile patients?
    Johnson FR; Ozdemir S; Mansfield C; Hass S; Siegel CA; Sands BE
    Risk Anal; 2009 Jan; 29(1):121-36. PubMed ID: 18826414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control in a National Program for the Early Detection of Breast Cancer: women's satisfaction with the mammography process.
    Almog R; Hagoel L; Tamir A; Barnett O; Rennert G
    Womens Health Issues; 2008; 18(2):110-7. PubMed ID: 18319148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy after the Women's Health Initiative: a qualitative study.
    French LM; Smith MA; Holtrop JS; Holmes-Rovner M
    BMC Fam Pract; 2006 Oct; 7():61. PubMed ID: 17059606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms.
    Johnson FR; Hauber AB; Ozdemir S
    Value Health; 2009; 12(1):146-52. PubMed ID: 19911445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different ways to describe the benefits of risk-reducing treatments: a randomized trial.
    Halvorsen PA; Selmer R; Kristiansen IS
    Ann Intern Med; 2007 Jun; 146(12):848-56. PubMed ID: 17577004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
    Wilson L; Loucks A; Bui C; Gipson G; Zhong L; Schwartzburg A; Crabtree E; Goodin D; Waubant E; McCulloch C
    J Neurol Sci; 2014 Sep; 344(1-2):80-7. PubMed ID: 25037284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of patients' willingness to trade symptom-free days for asthma-related treatment risks: a discrete choice experiment.
    McTaggart-Cowan HM; Shi P; Fitzgerald JM; Anis AH; Kopec JA; Bai TR; Soon JA; Lynd LD
    J Asthma; 2008 Oct; 45(8):630-8. PubMed ID: 18951253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the understanding of the risks and benefits of hormone replacement therapy (HRT) in primary care physicians.
    Williams RS; Christie D; Sistrom C
    Am J Obstet Gynecol; 2005 Aug; 193(2):551-6; discussion 556-8. PubMed ID: 16098892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to accept chemotherapy and attitudes towards costs of cancer treatment; A multisite survey study in the Netherlands.
    van Dijk EF; Coşkuntürk M; Zuur AT; van der Palen J; van der Graaf WT; Timmer-Bonte JN; Wymenga AN
    Neth J Med; 2016 Aug; 74(7):292-300. PubMed ID: 27571944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study.
    Sveinsdóttir H; Olafsson RF
    J Adv Nurs; 2006 Jun; 54(5):572-84. PubMed ID: 16722955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's perceptions of hormone replacement therapy: risks and benefits (1980-2002). A literature review.
    Buick DL; Crook D; Horne R
    Climacteric; 2005 Mar; 8(1):24-35. PubMed ID: 15804729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy.
    Johnson FR; Van Houtven G; Ozdemir S; Hass S; White J; Francis G; Miller DW; Phillips JT
    J Neurol; 2009 Apr; 256(4):554-62. PubMed ID: 19444531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's views on chemoprevention of breast cancer: qualitative study.
    Heisey R; Pimlott N; Clemons M; Cummings S; Drummond N
    Can Fam Physician; 2006 May; 52(5):624-5. PubMed ID: 17327893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.
    Heinemann K; Rübig A; Strothmann A; Nahum GG; Heinemann LA
    J Womens Health (Larchmt); 2008 Sep; 17(7):1151-66. PubMed ID: 18774896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are older breast carcinoma survivors willing to take hormone replacement therapy?
    Ganz PA; Greendale GA; Kahn B; O'Leary JF; Desmond KA
    Cancer; 1999 Sep; 86(5):814-20. PubMed ID: 10463980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.